Skip to main content

Table 1 Baseline characteristics of children on HAART Treated in four ART # Centers in Addis Ababa, Ethiopia followed from 2005–2011

From: Predictors of treatment failure and time to detection and switching in HIV-infected Ethiopian children receiving first line anti-retroviral therapy

Characteristic

Number (%)

Age

 

 -≤ 11 months

46(3.9 )

 -11 to 34

169 (14.2)

 -34 to 59

212 (17.9)

 -≥60 month

759 (64)

Sex

 

 -Female

608 (51.2%)

 -Male

578 (48.8%)

Duration of Follow up

 

 -Less than one year

265(22.3)

 -One to two years

270(22.8)

 -Two to three years

248(20.9)

 -Three to four years

225(19.0)

 -More than four years

178(15.0)

Parental status

 

 -Both alive

427(36.96)

 -Either dead

468(40.51)

 -Both dead

260(22.5)

 -Unknown

31 (2.6)

Serology of the care takers

 

 -Positive

773(65.2)

 -Negative

55(4.6)

 -Unknown

358(30.2)

Primary care taker

 

 -Both parents

415(35)

 -Mother

249(21)

 -Father

156(13.2)

 -Relatives

125(10.5)

 -Guardians /neighbors

142(12)

 -Orphange

99(8.3)

WHO stage

 

 -I

42(3.5)

 -II

305(25.7)

 -III

626(52.8)

 -IV

213(18)

Weight –for- Age

 

 -Below 3rd centile

172(14.5)

 ->3rd centile < 97th centile

192(16.2)

 -Above 97th centile

44(3.7)

 -Unknown

778 (65.6)

Height- for- Age

 

 -Below 3rd centile

327(27.6)

 ->3rd centile < 97th centile

763(6.3)

 -Above 97th centile

81(6.8)

 -Unknown

15(1.3)

Weight- for –Height

 

 -Below 3rd centile

105(8.9)

 ->3rd centile < 97th centile

245(20.7)

 -Above 97th centile

707(59.6)

 -Unknown

129(10.9)

Regimen started at initiation of ART

 

 -4a (D4T + 3TC + NVP)

388(32.7)

 -4b(D4T + 3TC + EFV)

106(8.9)

 -4c(ZDV + 3TC + NVP)

300(25.3)

 -4d(ZDV + 3TC + EFV)

361(30.4)

Infant ART prophylaxis

 

 -NVP

9(0.8)

 -NVP + ZDV

977(82.4)

 -None

977(82.4)

 -Unknown

181(15.3)

Immunosupression at initiation of ART $

 

 -Not Significant

160(13.5)

 -Mild Immunosupression

145(12.2)

 -Advanced Immunosupression

331(27.9)

 -Severe Immunosupression

450(37.9)

 -Unknown

100(8.4)

Chronic Diarrhea after initiation

 

 -Yes

16 (1.3)

 -None

1170(98.7)

  1. € Highly Active Antiretroviral Therapy # Antiretroviral Therapy $ Level of immunosupression is based on the Ethiopian National ART guideline [10].